Detalles de la búsqueda
1.
A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.
BMC Cancer
; 19(1): 290, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30935375
Resultados
1 -
1
de 1
1
Próxima >
>>